We are live on ! Find out more
AYTU icon

AYTU BioPharma
AYTU

36 hedge funds and large institutions have $1.54M invested in AYTU BioPharma in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

0.06% less ownership

Funds ownership: 0.71% → 0.64% (-0.06%)

7% less capital invested

Capital invested by funds: $1.65M → $1.54M (-$115K)

14% less funds holding

Funds holding: 42 → 36 (-6)

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
36
Holders Change
-6
Holders Change %
-14.29%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
12
Reduced
10
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$147K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$74.9K
3
Renaissance Technologies
Renaissance Technologies
New York
+$74K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$18.8K
5
Jane Street
Jane Street
New York
+$14.7K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$234K
2
Walleye Capital
Walleye Capital
New York
-$108K
3
AC
Ayrton Capital
Connecticut
-$84K
4
CH
CVI Holdings
Delaware
-$26K
5
WAM
Warberg Asset Management
Illinois
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$1K -$19 -5 -2%
BTI
27
Blue Trust Inc
Georgia
$1K – – –
UBS Group
28
UBS Group
Switzerland
$991 -$9.79K -2,600 -91%
Federated Hermes
29
Federated Hermes
Pennsylvania
$860 -$230 -61 -21%
Wells Fargo
30
Wells Fargo
California
$554 +$4 +1 +0.7%
Bank of America
31
Bank of America
North Carolina
$252 +$45 +12 +22%
MCC
32
Money Concepts Capital
Florida
$9 +$11 +3 New
LFG
33
Larson Financial Group
Missouri
$2 – – –
SM
34
Sabby Management
Florida
– -$234K -63,126 Closed
Walleye Capital
35
Walleye Capital
New York
– -$108K -29,125 Closed
AC
36
Ayrton Capital
Connecticut
– -$84K -22,611 Closed
CH
37
CVI Holdings
Delaware
– -$26K -7,094 Closed
WAM
38
Warberg Asset Management
Illinois
– -$12K -3,250 Closed
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
– -$10K -2,819 Closed
TSS
40
Two Sigma Securities
New York
– -$4K -1,026 Closed
Fidelity Investments
41
Fidelity Investments
Massachusetts
– -$2K -600 Closed
Simplex Trading
42
Simplex Trading
Illinois
– -$772 -205 -98%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
– -$97 -26 Closed
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
– +$8 +2 +8%
NA
45
NewEdge Advisors
Louisiana
– +$83 +22 New
1
2

AYTU Hedge Fund Activity: Q4 2022 in Review

36 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q4 2022, worth a combined $1.54M — down 7% from $1.65M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of AYTU and 5 opened new positions — a net loss of 6 holders — while 10 trimmed existing stakes and 12 added.

The largest buyer was Millennium Management, adding an estimated $147K. The largest seller was Sabby Management, exiting entirely with an estimated $234K sold.

  • 36 institutional investors held AYTU BioPharma (AYTU) as of Q4 2022, down from 42 in Q3 2022.
  • Funds reported $1.54M of AYTU BioPharma stock for Q4 2022, down 7% quarter-over-quarter.
  • 5 funds opened new AYTU BioPharma positions in Q4 2022 and 11 closed out, a net change of -6 holders.
  • The largest AYTU BioPharma buyer in Q4 2022 was Millennium Management, an estimated $147K added.
  • The largest AYTU BioPharma seller in Q4 2022 was Sabby Management, an estimated $234K sold.

Based on aggregated 13F filings for Q4 2022.